These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19874853)

  • 1. Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.
    Gowen BB; Wong MH; Jung KH; Smee DF; Morrey JD; Furuta Y
    Antiviral Res; 2010 May; 86(2):121-7. PubMed ID: 19874853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.
    Gowen BB; Wong MH; Jung KH; Sanders AB; Mendenhall M; Bailey KW; Furuta Y; Sidwell RW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3168-76. PubMed ID: 17606691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
    Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1.
    Gowen BB; Wong MH; Jung KH; Blatt LM; Sidwell RW
    Antiviral Res; 2008 Mar; 77(3):215-24. PubMed ID: 18222548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.
    Gowen BB; Westover JB; Miao J; Van Wettere AJ; Rigas JD; Hickerson BT; Jung KH; Li R; Conrad BL; Nielson S; Furuta Y; Wang Z
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.
    Mendenhall M; Wong MH; Skirpstunas R; Morrey JD; Gowen BB
    Virology; 2009 Dec; 395(1):143-51. PubMed ID: 19783024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705).
    Song R; Chen Z; Li W
    Infection; 2020 Apr; 48(2):295-298. PubMed ID: 31673977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir.
    Westover JB; Rigas JD; Van Wettere AJ; Li R; Hickerson BT; Jung KH; Miao J; Reynolds ES; Conrad BL; Nielson S; Furuta Y; Thangamani S; Wang Z; Gowen BB
    Virology; 2017 Nov; 511():175-183. PubMed ID: 28865344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
    Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
    Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy.
    Saijo M
    J Infect Chemother; 2018 Oct; 24(10):773-781. PubMed ID: 30098914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Julander JG; Furuta Y; Shafer K; Sidwell RW
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
    Furuta Y; Takahashi K; Shiraki K; Sakamoto K; Smee DF; Barnard DL; Gowen BB; Julander JG; Morrey JD
    Antiviral Res; 2009 Jun; 82(3):95-102. PubMed ID: 19428599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
    Gowen BB; Smee DF; Wong MH; Hall JO; Jung KH; Bailey KW; Stevens JR; Furuta Y; Morrey JD
    PLoS One; 2008; 3(11):e3725. PubMed ID: 19008960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
    Mendenhall M; Russell A; Smee DF; Hall JO; Skirpstunas R; Furuta Y; Gowen BB
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.
    Sidwell RW; Huffman JH; Barnard DL; Smee DF; Warren RP; Chirigos MA; Kende M; Huggins J
    Antiviral Res; 1994 Oct; 25(2):105-22. PubMed ID: 7847873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2'-Fluoro-2'-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models.
    Smee DF; Jung KH; Westover J; Gowen BB
    Antiviral Res; 2018 Dec; 160():48-54. PubMed ID: 30339848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of real-time reverse transcriptase qPCR assays for the detection of Punta Toro virus and Pichinde virus.
    Stefan CP; Chase K; Coyne S; Kulesh DA; Minogue TD; Koehler JW
    Virol J; 2016 Mar; 13():54. PubMed ID: 27029488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.
    Tani H; Komeno T; Fukuma A; Fukushi S; Taniguchi S; Shimojima M; Uda A; Morikawa S; Nakajima N; Furuta Y; Saijo M
    PLoS One; 2018; 13(10):e0206416. PubMed ID: 30365543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.